Nearly 50% of eyes with wet age-related macular degeneration (AMD) have stable or improved vision after long-term, 8-year pro re nata (PRN) treatment with ranibizumab, according to a group of U.K. clinicians.
This article was reviewed by Joanne Shen, MD
This article was reviewed by Andrea A. Tooley, MD
According to Andrea A. Tooley, MD, 3D printing for surgical applications is not the future of ophthalmology. It is the present.
This article was reviewed by Irmgard Behlau, MD
Segment 9. Experts discuss the effect of preservatives in topical medications on the ocular surface and newer agents like bimatoprost SR to overcome these limitations.
This article was reviewed by Noel A. Alpins, MD
Editor’s Note: Welcome to “Let's Chat,” a blog series featuring contributions from members of the ophthalmic community.
An internationally renowned working group of retina specialists, ocular imaging experts, and ocular pathologists have suggested standardizing definitions for age-related macular degeneration (AMD) and its subtypes.
Optometry Australia has developed an AMD chairside reference in consultation with a member-based working group comprised of experienced practitioners.